Insiders Just Boarded: Will NCLH’s Next Port Be Higher Prices?
Three top insiders at Norwegian Cruise Line (NCLH) bought shares on the same day—while bookings hit records and revenue sails higher. Debt is still the big wave to watch, but valuation looks reasonable for a cyclical. Here’s what cluster buys, guidance, and leverage really mean for the stock.
Two Directors Are Buying Clarivate. Should You Buy CLVT?
Two Clarivate directors just made multi-million-dollar insider buys, betting that the data-intelligence firm’s turnaround is for real. The company is paying down debt, buying back shares, and leaning hard into AI-driven analytics. But is this a deep-value opportunity — or just another corporate clarinet solo waiting to go off-key? 🎶
President & CEO Bought Shares of Enphase Energy: Time To Buy ENPH?
Enphase’s stock has been sunburned — but its CEO is buying, institutions are still in, and the long-term clean-energy runway remains bright. We dig into the numbers, the market mood, and whether ENPH could be an early-cycle solar rebound opportunity or a falling panel. ☀️📉➡️⚡️📈
CEO/COB at Cigna Is Buying CI. Is He Signaling: Time To Buy?
Cigna’s CEO is buying big — and Wall Street is paying attention. With earnings up, a pharmacy-benefit shake-up underway, and valuations looking healthy, CI might just be the quiet value stock investors have been waiting for. Let’s break it down — and have fun doing it. 😎💊📈
Two Directors Bought Shares of Everest Group (EG) Cheaper Than the CEO Did 6 Months Ago: Will Buying Now Culminate in Profits?
Two Everest Group directors just bought stock around $306–$307—below the CEO’s June buy—while the company cleans house with a $1.2B adverse development cover and a renewal-rights sale to AIG. Institutions own essentially all the float, short interest is low, and forward P/E looks cheap. Here’s the risk/reward.
Investor & Insider James Breyer Just Bought Blackstone (BX). Should You Sip the Alt-Assets Kool-Aid—or Sit It Out?
Blackstone remains the alt-assets apex predator: $1.24T AUM, rising perpetual capital, and a fresh insider buy from director James Breyer. We unpack fundraising momentum, distributable earnings, variable dividends, key risks (rates, exits), and why dips may be gifts for long-term investors.
CEO Bought Shares of Booz Allen Hamilton: Time to Indulge
Booz Allen just flashed insider conviction: CEO Horacio Rozanski purchased ~$2M of BAH stock. Despite near-term revenue pressure from funding delays, the firm sports a record backlog, mission-critical AI/cyber programs, and steady capital returns. We unpack the bull/bear, valuation, and what could flip the narrative from pause to play.
A Director Bought Shares of Coca-Cola (KO) Hoping They’ll Sparkle; Should You—Or Will They Fizzle Out?
A fresh insider buy from new director Max Levchin adds fizz to Coca-Cola’s already solid fundamentals: mid-single-digit organic growth, fortress cash flow, and a Dividend King pedigree. We break down the bull/bear case, valuation, and why KO still shines—especially on dips.
CEO, COB, President All Bought Shares of FTI Consulting (FCN). It’s the Same Person—Still… Should You Buy Too?
FTI Consulting just posted record EPS while its tri-titled chief bought $1.13M of stock and the board added $500M to buybacks. A cycle-balanced franchise that compounds through booms, busts, and boardroom “oh-no’s.”
Cohen & Steers (CNS): Chairman Buys Millions—Time To Clip the Coupon or Clip Your Wings?
CNS shows mid-single-digit revenue growth, double-digit EPS growth, and a fresh $2.85M insider buy. Real-asset optionality, de-foamed multiple, TL;DR + FAQs.